Epidemiology and antimicrobial resistance of Streptococcus pneumoniae in Aquitaine in 2001

被引:1
|
作者
Maugein, J
Fourche, J
Brachet-Castang, C
Bezian, MC
Boineau, F
Brochet, JP
Cancey, B
Cassignard, D
Denjean, MP
Dutilh, B
El Harif, Z
Fabe, C
Fischer, I
Fourmau, S
Grobost, F
Lafargue, JP
Larrouy, G
Lehours, P
Rougier, C
Sanchez, R
Tamarelle, C
机构
[1] CHU Bordeaux, Hop Haut Leveque, Bacteriol Lab, F-33604 Pessac, France
[2] CHU Bordeaux, Hop St Andre, F-33000 Bordeaux, France
[3] CHU Bordeaux, Hop Pellegrin, F-33000 Bordeaux, France
[4] LAM Exalab, F-33000 Bordeaux, France
[5] CH, F-47307 Villeneuve Sur Lot, France
[6] CHIC, F-47207 Marmande, France
[7] CH, F-47023 Agen, France
[8] LAM Marsan & Associes, F-33000 Bordeaux, France
[9] CH, F-33505 Libourne, France
[10] CH, F-24108 Bergerac, France
[11] Lam Ruffie & Associes, F-33000 Bordeaux, France
[12] LAM Huchon & Associes, F-33390 Blaye, France
[13] LAM, F-64202 Biarritz, France
[14] CH, F-40107 Dax, France
[15] CH, F-33111 Arcachon, France
[16] CHU Bordeaux, Hop Enfants, F-33000 Bordeaux, France
[17] CH, F-40024 Mont De Marsan, France
[18] CH, F-24019 Perpigueux, France
[19] CH, F-33212 Langon, France
来源
MEDECINE ET MALADIES INFECTIEUSES | 2003年 / 33卷 / 05期
关键词
antimicrobial resistance; Streptococcus pneumoniae;
D O I
10.1016/S0399-077X(03)00108-2
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective. - We aimed to assess the level of S. pneumoniae resistance to antibiotics in Aquitaine. Method. - In 2001, 19 microbiological laboratories collected a total of 716 clinical isolates of Streptococcus pneumoniae. Results. - Nineteen per cent were isolated from children under 6 years of age and 60% from adults above 40 years of age. The percentage of strains isolated from the blood of patients above 80 years of age was the highest (38%). In pulmonary samples the highest percentage was found in patients between 40 and 80 years of age (71-75%) and from OMA in children under 6 years of age. Serotypes 19,14, and 23 were the most frequent (18, 16.6 and 14.6%). The serotypes selected in the heptavalent vaccine covered 70% of the isolates. Out of the 716 isolates, 59% showed a decreased susceptibility to penicillin G, 21% of the strains were strongly resistant to penicillin but only 1.1% to amoxicillin and none to cefotaxime and ceftriaxone. The rate of resistance to non beta-lactams agents were as follows: erythromycin 61.5%, tetracycline 27%, and cotrimoxazole 34.6%. No resistance to vancomycin was observed and resistance to rifampicin remained very rare (0.2%). Eleven (2.2%) of the 504 studied strains were resistant to fluoroquinolones. Comments. - Old age, male sex, and hospitalization seemed to be risk factors leading to selection of these strains. (C) 2003 Editions scientifiques et medicales Elsevier SAS. All rights reserved.
引用
收藏
页码:247 / 253
页数:7
相关论文
共 50 条
  • [1] Epidemiology and antimicrobial resistance of Streptococcus pneumoniae strains isolated in Ile de France area during 2001
    Demachy, MC
    Faibis, F
    Artigou, A
    Benoit, C
    Cambau, E
    Cecille, A
    Chachaty, E
    Chaplain, C
    Cormier, P
    Cousinard, F
    Decotte, JC
    Demontrond, D
    Dublanchet, A
    Dupeyron, C
    Farges, A
    Ferre, B
    Fremaux, A
    Galanti, MJ
    Gallet, C
    Guiet, P
    Hacquard, B
    Hornstein, M
    Legrand, P
    Le Manach, F
    Lucet, N
    Malbrunot, C
    Mangeol, A
    Mathieu, D
    Otterbein, G
    Pateyron, F
    Poilane, I
    Pollet, J
    Rabenja, T
    Spicq, C
    [J]. MEDECINE ET MALADIES INFECTIEUSES, 2004, 34 (07): : 303 - 309
  • [2] Streptococcus pneumoniae:: Epidemiology and patterns of resistance
    Jacobs, MR
    [J]. AMERICAN JOURNAL OF MEDICINE, 2004, 117 : 3 - 15
  • [3] Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines
    Lynch, Joseph P., III
    Zhanel, George G.
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2010, 16 (03) : 217 - 225
  • [4] Antimicrobial resistance in Streptococcus pneumoniae, Taiwan
    Hsueh, PR
    Luh, KT
    [J]. EMERGING INFECTIOUS DISEASES, 2002, 8 (12) : 1487 - 1491
  • [5] The antimicrobial resistance profile of Streptococcus pneumoniae
    Reinert, R. R.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2009, 15 : 7 - 11
  • [6] Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniae
    Riedel, S.
    Beekmann, S. E.
    Heilmann, K. P.
    Richter, S. S.
    Garcia-de-Lomas, J.
    Ferech, M.
    Goosens, H.
    Doern, G. V.
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2007, 26 (07) : 485 - 490
  • [7] Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniae
    S. Riedel
    S. E. Beekmann
    K. P. Heilmann
    S. S. Richter
    J. Garcia-de-Lomas
    M. Ferech
    H. Goosens
    G. V. Doern
    [J]. European Journal of Clinical Microbiology & Infectious Diseases, 2007, 26
  • [8] Drug resistance in Streptococcus pneumoniae:: epidemiology and control
    Kalin, M
    Kristinsson, KG
    [J]. BAILLIERES CLINICAL INFECTIOUS DISEASES, 1999, 5 (02): : 203 - 219
  • [9] Clinical significance of antimicrobial resistance in Streptococcus pneumoniae
    Jacobs, Michael R.
    [J]. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2007, 97 (11): : 1133 - 1140
  • [10] Streptococcus pneumoniae: Does Antimicrobial Resistance Matter?
    Lynch, Joseph P., III
    Zhanel, George G.
    [J]. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 30 (02) : 210 - 238